Academic Journal
Mutant huntingtin expression in somatostatin-positive interneurons contributes to neurophysiological and behavioral phenotypes in BACHD mice.
| Title: | Mutant huntingtin expression in somatostatin-positive interneurons contributes to neurophysiological and behavioral phenotypes in BACHD mice. |
|---|---|
| Authors: | Fowler JA; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.; Graduate Biomedical Sciences, Biochemistry and Structural Biology Theme, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA., Scarduzio M; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA., Pool C; College of Arts and Sciences, Xavier University of Louisiana, New Orleans, LA 70125, USA.; Summer in Biomedical Sciences (SIBS) Undergraduate Research Program, The University of Alabama at Birmingham, Birmingham, AL 35294, USA., Mahan CD; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA., Gray M; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA. |
| Source: | Disease models & mechanisms [Dis Model Mech] 2026 Mar 01; Vol. 19 (3). Date of Electronic Publication: 2026 Mar 27. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Company of Biologists Ltd Country of Publication: England NLM ID: 101483332 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-8411 (Electronic) Linking ISSN: 17548403 NLM ISO Abbreviation: Dis Model Mech Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Cambridge : Company of Biologists Ltd., c2008- |
| MeSH Terms: | Interneurons*/metabolism , Huntingtin Protein*/metabolism , Huntingtin Protein*/genetics , Somatostatin*/metabolism , Mutation*/genetics , Mutant Proteins*/metabolism , Behavior, Animal*, Anxiety/physiopathology ; Anxiety/complications ; Huntington Disease/physiopathology ; Animals ; Phenotype ; Male ; Motor Activity ; Mice |
| Abstract: | Huntington's disease (HD) is caused by expansion of the polyglutamine stretch in the widely expressed huntingtin (HTT) protein. Patients with HD have motor, psychiatric and cognitive changes due to changes in a variety of neural circuits. Somatostatin-expressing interneurons (SST-INs) can regulate neural circuits largely by inhibiting their target cells. Behaviorally, brain-wide inhibition of SST-INs increased anxiety in mice. Silencing striatal SST-INs caused a decrease in movement in the open field. Mutant HTT (mHTT)-expressing mice exhibited abnormal motor, cognitive and psychiatric-like changes, as well as electrophysiological changes in a variety of neurons, including striatal SST-INs. However, it is unknown whether cell-autonomous expression of mHTT in SST-INs contributes to HD-associated behavioral phenotypes or causes abnormal electrophysiological changes in striatal SST-INs. To address these questions, we reduced mHTT expression in SST-INs throughout the brain of BACHD mice. Our findings show that brain-wide reduction of mHTT in SST-INs rescues anxiety-like behavior in male BACHD mice in the light-dark box, without improving performance in the open field or on the rotarod. Additionally, expression of mHTT in striatal SST-INs cell autonomously drives their increased excitability. (© 2026. Published by The Company of Biologists.) |
| Competing Interests: | Competing interests The authors declare no competing or financial interests. |
| References: | Front Neuroanat. 2018 Nov 08;12:91. (PMID: 30467465) J Neurosci. 2011 Jan 26;31(4):1170-82. (PMID: 21273402) Int J Neuropsychopharmacol. 2021 Jul 14;24(6):505-518. (PMID: 33438026) Science. 2019 Jan 25;363(6425):413-417. (PMID: 30679375) Neuron. 2024 Apr 3;112(7):1182-1195.e5. (PMID: 38266646) Cell. 1993 Mar 26;72(6):971-83. (PMID: 8458085) Neuroimage Clin. 2018 Mar 22;18:881-887. (PMID: 29876272) Cell Rep. 2025 May 27;44(5):115670. (PMID: 40333184) PLoS One. 2009;4(3):e4770. (PMID: 19274089) Elife. 2022 Jan 13;11:. (PMID: 35023827) iScience. 2023 Sep 14;26(10):107918. (PMID: 37817932) J Neurosci. 2013 Apr 24;33(17):7393-406. (PMID: 23616545) Neurobiol Dis. 2009 Sep;35(3):319-36. (PMID: 19464370) Front Neuroanat. 2021 May 24;15:673177. (PMID: 34108866) Exp Neurol. 2020 Aug;330:113358. (PMID: 32387649) Australas Psychiatry. 2018 Aug;26(4):366-375. (PMID: 30012004) Cell. 2018 Aug 9;174(4):1015-1030.e16. (PMID: 30096299) Int J Mol Sci. 2021 May 30;22(11):. (PMID: 34070785) Front Neuroanat. 2010 Dec 29;4:150. (PMID: 21228905) Eur J Neurol. 2018 Jan;25(1):24-34. (PMID: 28817209) Transl Psychiatry. 2019 Nov 11;9(1):292. (PMID: 31712551) Neuroscience. 1998 Sep;86(2):353-87. (PMID: 9881853) Nat Genet. 1993 Aug;4(4):398-403. (PMID: 8401589) Front Neurosci. 2022 Sep 26;16:1022251. (PMID: 36225731) J Huntingtons Dis. 2018;7(3):355-366. (PMID: 30040737) Nat Genet. 1993 Aug;4(4):393-7. (PMID: 8401588) J Neurochem. 2010 Jun;113(5):1073-91. (PMID: 20236390) Neuron. 2016 Oct 5;92(1):84-92. (PMID: 27710792) Nat Genet. 1993 Jul;4(3):221-6. (PMID: 8358429) J Neuropathol Exp Neurol. 1995 Jan;54(1):105-20. (PMID: 7815073) Proc Natl Acad Sci U S A. 2016 May 17;113(20):5736-41. (PMID: 27140644) Curr Trends Neurol. 2011 Jan 1;5:65-78. (PMID: 22180703) J Neurosci. 2013 Nov 20;33(47):18531-9. (PMID: 24259575) Trends Neurosci. 2004 Nov;27(11):662-9. (PMID: 15474166) Neuron. 2011 Sep 22;71(6):995-1013. (PMID: 21943598) Neuron. 2016 Mar 2;89(5):910-26. (PMID: 26938440) Biomolecules. 2022 Feb 15;12(2):. (PMID: 35204812) Orphanet J Rare Dis. 2010 Dec 20;5:40. (PMID: 21171977) Eur J Neurosci. 2019 Jan;49(1):79-93. (PMID: 30472747) Exp Neurol. 1997 Apr;144(2):239-47. (PMID: 9168825) Mov Disord. 2013 Oct;28(12):1691-9. (PMID: 24014043) Neuron. 1995 May;14(5):1065-74. (PMID: 7748554) Cell Rep. 2022 Jul 19;40(3):111111. (PMID: 35858550) Eur J Neurol. 2023 Sep;30(9):2650-2660. (PMID: 37306313) Neuron. 1995 May;14(5):1075-81. (PMID: 7748555) Neuroreport. 1999 Dec 16;10(18):3891-6. (PMID: 10716229) J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77. (PMID: 2932539) J Neurosci. 2008 Jun 11;28(24):6182-95. (PMID: 18550760) Hum Mol Genet. 2019 Feb 1;28(3):487-500. (PMID: 30312396) Nat Med. 2014 May;20(5):536-41. (PMID: 24784230) J Electron Microsc Tech. 1988 Nov;10(3):265-81. (PMID: 3069970) Trends Neurosci. 2012 Sep;35(9):557-64. (PMID: 22858522) Front Cell Neurosci. 2021 Jun 15;15:689332. (PMID: 34211373) Adv Exp Med Biol. 2018;1049:1-28. (PMID: 29427096) J Comp Neurol. 1996 Jun 17;370(1):11-22. (PMID: 8797153) Mov Disord. 1999 May;14(3):398-403. (PMID: 10348461) Brain Res. 1996 Oct 7;735(2):317-24. (PMID: 8911672) Ann Neurol. 1995 Dec;38(6):852-61. (PMID: 8526457) Neuroscientist. 2019 Oct;25(5):475-490. (PMID: 30678530) J Cell Biol. 2005 Dec 19;171(6):1001-12. (PMID: 16365166) Neuroscientist. 2019 Aug;25(4):359-379. (PMID: 30379121) Curr Opin Neurobiol. 2004 Dec;14(6):685-92. (PMID: 15582369) Cureus. 2022 Apr 25;14(4):e24473. (PMID: 35651462) J Neurosci. 1991 Dec;11(12):3877-87. (PMID: 1836019) Front Synaptic Neurosci. 2019 May 14;11:14. (PMID: 31139071) Neuroendocrinology. 1996 Feb;63(2):181-7. (PMID: 9053783) J Anat. 2000 May;196 ( Pt 4):527-42. (PMID: 10923985) Dis Model Mech. 2024 Nov 1;17(11):. (PMID: 39526491) Neuron. 2016 Jul 20;91(2):260-92. (PMID: 27477017) |
| Grant Information: | 5R01NS089750 United States NS NINDS NIH HHS; Jarman F. Lowder Endowment; Hereditary Disease Foundation; University of Alabama at Birmingham |
| Contributed Indexing: | Keywords: BACHD; Huntington's disease; Interneurons; Somatostatin; Striatum |
| Substance Nomenclature: | 0 (Huntingtin Protein) 51110-01-1 (Somatostatin) 0 (Mutant Proteins) |
| Entry Date(s): | Date Created: 20260206 Date Completed: 20260707 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13054931 |
| DOI: | 10.1242/dmm.052513 |
| PMID: | 41648922 |
| Database: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=17548411&ISBN=&volume=19&issue=3&date=20260301&spage=&pages=&title=Disease models & mechanisms&atitle=Mutant%20huntingtin%20expression%20in%20somatostatin-positive%20interneurons%20contributes%20to%20neurophysiological%20and%20behavioral%20phenotypes%20in%20BACHD%20mice.&aulast=Fowler%20JA&id=DOI:10.1242/dmm.052513 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41648922 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mutant huntingtin expression in somatostatin-positive interneurons contributes to neurophysiological and behavioral phenotypes in BACHD mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fowler+JA%22">Fowler JA</searchLink>; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.; Graduate Biomedical Sciences, Biochemistry and Structural Biology Theme, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.<br /><searchLink fieldCode="AU" term="%22Scarduzio+M%22">Scarduzio M</searchLink>; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.<br /><searchLink fieldCode="AU" term="%22Pool+C%22">Pool C</searchLink>; College of Arts and Sciences, Xavier University of Louisiana, New Orleans, LA 70125, USA.; Summer in Biomedical Sciences (SIBS) Undergraduate Research Program, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.<br /><searchLink fieldCode="AU" term="%22Mahan+CD%22">Mahan CD</searchLink>; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA.<br /><searchLink fieldCode="AU" term="%22Gray+M%22">Gray M</searchLink>; Department of Neurology, Killion Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL 35294, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101483332%22">Disease models & mechanisms</searchLink> [Dis Model Mech] 2026 Mar 01; Vol. 19 (3). <i>Date of Electronic Publication: </i>2026 Mar 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Company+of+Biologists+Ltd%22">Company of Biologists Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101483332 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1754-8411 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217548403%22">17548403 </searchLink><i>NLM ISO Abbreviation: </i>Dis Model Mech <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Cambridge : Company of Biologists Ltd., c2008- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Interneurons%22">Interneurons*</searchLink>/<searchLink fieldCode="MM" term="%22Interneurons+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Huntingtin+Protein%22">Huntingtin Protein*</searchLink>/<searchLink fieldCode="MM" term="%22Huntingtin+Protein+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Huntingtin+Protein%22">Huntingtin Protein*</searchLink>/<searchLink fieldCode="MM" term="%22Huntingtin+Protein+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Somatostatin%22">Somatostatin*</searchLink>/<searchLink fieldCode="MM" term="%22Somatostatin+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutation%22">Mutation*</searchLink>/<searchLink fieldCode="MM" term="%22Mutation+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Mutant+Proteins%22">Mutant Proteins*</searchLink>/<searchLink fieldCode="MM" term="%22Mutant+Proteins+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Behavior%2C+Animal%22">Behavior, Animal*</searchLink><br /><searchLink fieldCode="MH" term="%22Anxiety%22">Anxiety</searchLink>/<searchLink fieldCode="MH" term="%22Anxiety+physiopathology%22">physiopathology</searchLink> ; <searchLink fieldCode="MH" term="%22Anxiety%22">Anxiety</searchLink>/<searchLink fieldCode="MH" term="%22Anxiety+complications%22">complications</searchLink> ; <searchLink fieldCode="MH" term="%22Huntington+Disease%22">Huntington Disease</searchLink>/<searchLink fieldCode="MH" term="%22Huntington+Disease+physiopathology%22">physiopathology</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Phenotype%22">Phenotype</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Motor+Activity%22">Motor Activity</searchLink> ; <searchLink fieldCode="MH" term="%22Mice%22">Mice</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Huntington's disease (HD) is caused by expansion of the polyglutamine stretch in the widely expressed huntingtin (HTT) protein. Patients with HD have motor, psychiatric and cognitive changes due to changes in a variety of neural circuits. Somatostatin-expressing interneurons (SST-INs) can regulate neural circuits largely by inhibiting their target cells. Behaviorally, brain-wide inhibition of SST-INs increased anxiety in mice. Silencing striatal SST-INs caused a decrease in movement in the open field. Mutant HTT (mHTT)-expressing mice exhibited abnormal motor, cognitive and psychiatric-like changes, as well as electrophysiological changes in a variety of neurons, including striatal SST-INs. However, it is unknown whether cell-autonomous expression of mHTT in SST-INs contributes to HD-associated behavioral phenotypes or causes abnormal electrophysiological changes in striatal SST-INs. To address these questions, we reduced mHTT expression in SST-INs throughout the brain of BACHD mice. Our findings show that brain-wide reduction of mHTT in SST-INs rescues anxiety-like behavior in male BACHD mice in the light-dark box, without improving performance in the open field or on the rotarod. Additionally, expression of mHTT in striatal SST-INs cell autonomously drives their increased excitability.<br /> (© 2026. Published by The Company of Biologists.) – Name: Abstract Label: Competing Interests Group: Ab Data: Competing interests The authors declare no competing or financial interests. – Name: Ref Label: References Group: RefInfo Data: Front Neuroanat. 2018 Nov 08;12:91. (PMID: <searchLink fieldCode="PM" term="%2230467465%22">30467465)</searchLink><br />J Neurosci. 2011 Jan 26;31(4):1170-82. (PMID: <searchLink fieldCode="PM" term="%2221273402%22">21273402)</searchLink><br />Int J Neuropsychopharmacol. 2021 Jul 14;24(6):505-518. (PMID: <searchLink fieldCode="PM" term="%2233438026%22">33438026)</searchLink><br />Science. 2019 Jan 25;363(6425):413-417. (PMID: <searchLink fieldCode="PM" term="%2230679375%22">30679375)</searchLink><br />Neuron. 2024 Apr 3;112(7):1182-1195.e5. (PMID: <searchLink fieldCode="PM" term="%2238266646%22">38266646)</searchLink><br />Cell. 1993 Mar 26;72(6):971-83. (PMID: <searchLink fieldCode="PM" term="%228458085%22">8458085)</searchLink><br />Neuroimage Clin. 2018 Mar 22;18:881-887. (PMID: <searchLink fieldCode="PM" term="%2229876272%22">29876272)</searchLink><br />Cell Rep. 2025 May 27;44(5):115670. (PMID: <searchLink fieldCode="PM" term="%2240333184%22">40333184)</searchLink><br />PLoS One. 2009;4(3):e4770. (PMID: <searchLink fieldCode="PM" term="%2219274089%22">19274089)</searchLink><br />Elife. 2022 Jan 13;11:. (PMID: <searchLink fieldCode="PM" term="%2235023827%22">35023827)</searchLink><br />iScience. 2023 Sep 14;26(10):107918. (PMID: <searchLink fieldCode="PM" term="%2237817932%22">37817932)</searchLink><br />J Neurosci. 2013 Apr 24;33(17):7393-406. (PMID: <searchLink fieldCode="PM" term="%2223616545%22">23616545)</searchLink><br />Neurobiol Dis. 2009 Sep;35(3):319-36. (PMID: <searchLink fieldCode="PM" term="%2219464370%22">19464370)</searchLink><br />Front Neuroanat. 2021 May 24;15:673177. (PMID: <searchLink fieldCode="PM" term="%2234108866%22">34108866)</searchLink><br />Exp Neurol. 2020 Aug;330:113358. (PMID: <searchLink fieldCode="PM" term="%2232387649%22">32387649)</searchLink><br />Australas Psychiatry. 2018 Aug;26(4):366-375. (PMID: <searchLink fieldCode="PM" term="%2230012004%22">30012004)</searchLink><br />Cell. 2018 Aug 9;174(4):1015-1030.e16. (PMID: <searchLink fieldCode="PM" term="%2230096299%22">30096299)</searchLink><br />Int J Mol Sci. 2021 May 30;22(11):. (PMID: <searchLink fieldCode="PM" term="%2234070785%22">34070785)</searchLink><br />Front Neuroanat. 2010 Dec 29;4:150. (PMID: <searchLink fieldCode="PM" term="%2221228905%22">21228905)</searchLink><br />Eur J Neurol. 2018 Jan;25(1):24-34. (PMID: <searchLink fieldCode="PM" term="%2228817209%22">28817209)</searchLink><br />Transl Psychiatry. 2019 Nov 11;9(1):292. (PMID: <searchLink fieldCode="PM" term="%2231712551%22">31712551)</searchLink><br />Neuroscience. 1998 Sep;86(2):353-87. (PMID: <searchLink fieldCode="PM" term="%229881853%22">9881853)</searchLink><br />Nat Genet. 1993 Aug;4(4):398-403. (PMID: <searchLink fieldCode="PM" term="%228401589%22">8401589)</searchLink><br />Front Neurosci. 2022 Sep 26;16:1022251. (PMID: <searchLink fieldCode="PM" term="%2236225731%22">36225731)</searchLink><br />J Huntingtons Dis. 2018;7(3):355-366. (PMID: <searchLink fieldCode="PM" term="%2230040737%22">30040737)</searchLink><br />Nat Genet. 1993 Aug;4(4):393-7. (PMID: <searchLink fieldCode="PM" term="%228401588%22">8401588)</searchLink><br />J Neurochem. 2010 Jun;113(5):1073-91. (PMID: <searchLink fieldCode="PM" term="%2220236390%22">20236390)</searchLink><br />Neuron. 2016 Oct 5;92(1):84-92. (PMID: <searchLink fieldCode="PM" term="%2227710792%22">27710792)</searchLink><br />Nat Genet. 1993 Jul;4(3):221-6. (PMID: <searchLink fieldCode="PM" term="%228358429%22">8358429)</searchLink><br />J Neuropathol Exp Neurol. 1995 Jan;54(1):105-20. (PMID: <searchLink fieldCode="PM" term="%227815073%22">7815073)</searchLink><br />Proc Natl Acad Sci U S A. 2016 May 17;113(20):5736-41. (PMID: <searchLink fieldCode="PM" term="%2227140644%22">27140644)</searchLink><br />Curr Trends Neurol. 2011 Jan 1;5:65-78. (PMID: <searchLink fieldCode="PM" term="%2222180703%22">22180703)</searchLink><br />J Neurosci. 2013 Nov 20;33(47):18531-9. (PMID: <searchLink fieldCode="PM" term="%2224259575%22">24259575)</searchLink><br />Trends Neurosci. 2004 Nov;27(11):662-9. (PMID: <searchLink fieldCode="PM" term="%2215474166%22">15474166)</searchLink><br />Neuron. 2011 Sep 22;71(6):995-1013. (PMID: <searchLink fieldCode="PM" term="%2221943598%22">21943598)</searchLink><br />Neuron. 2016 Mar 2;89(5):910-26. (PMID: <searchLink fieldCode="PM" term="%2226938440%22">26938440)</searchLink><br />Biomolecules. 2022 Feb 15;12(2):. (PMID: <searchLink fieldCode="PM" term="%2235204812%22">35204812)</searchLink><br />Orphanet J Rare Dis. 2010 Dec 20;5:40. (PMID: <searchLink fieldCode="PM" term="%2221171977%22">21171977)</searchLink><br />Eur J Neurosci. 2019 Jan;49(1):79-93. (PMID: <searchLink fieldCode="PM" term="%2230472747%22">30472747)</searchLink><br />Exp Neurol. 1997 Apr;144(2):239-47. (PMID: <searchLink fieldCode="PM" term="%229168825%22">9168825)</searchLink><br />Mov Disord. 2013 Oct;28(12):1691-9. (PMID: <searchLink fieldCode="PM" term="%2224014043%22">24014043)</searchLink><br />Neuron. 1995 May;14(5):1065-74. (PMID: <searchLink fieldCode="PM" term="%227748554%22">7748554)</searchLink><br />Cell Rep. 2022 Jul 19;40(3):111111. (PMID: <searchLink fieldCode="PM" term="%2235858550%22">35858550)</searchLink><br />Eur J Neurol. 2023 Sep;30(9):2650-2660. (PMID: <searchLink fieldCode="PM" term="%2237306313%22">37306313)</searchLink><br />Neuron. 1995 May;14(5):1075-81. (PMID: <searchLink fieldCode="PM" term="%227748555%22">7748555)</searchLink><br />Neuroreport. 1999 Dec 16;10(18):3891-6. (PMID: <searchLink fieldCode="PM" term="%2210716229%22">10716229)</searchLink><br />J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77. (PMID: <searchLink fieldCode="PM" term="%222932539%22">2932539)</searchLink><br />J Neurosci. 2008 Jun 11;28(24):6182-95. (PMID: <searchLink fieldCode="PM" term="%2218550760%22">18550760)</searchLink><br />Hum Mol Genet. 2019 Feb 1;28(3):487-500. (PMID: <searchLink fieldCode="PM" term="%2230312396%22">30312396)</searchLink><br />Nat Med. 2014 May;20(5):536-41. (PMID: <searchLink fieldCode="PM" term="%2224784230%22">24784230)</searchLink><br />J Electron Microsc Tech. 1988 Nov;10(3):265-81. (PMID: <searchLink fieldCode="PM" term="%223069970%22">3069970)</searchLink><br />Trends Neurosci. 2012 Sep;35(9):557-64. (PMID: <searchLink fieldCode="PM" term="%2222858522%22">22858522)</searchLink><br />Front Cell Neurosci. 2021 Jun 15;15:689332. (PMID: <searchLink fieldCode="PM" term="%2234211373%22">34211373)</searchLink><br />Adv Exp Med Biol. 2018;1049:1-28. (PMID: <searchLink fieldCode="PM" term="%2229427096%22">29427096)</searchLink><br />J Comp Neurol. 1996 Jun 17;370(1):11-22. (PMID: <searchLink fieldCode="PM" term="%228797153%22">8797153)</searchLink><br />Mov Disord. 1999 May;14(3):398-403. (PMID: <searchLink fieldCode="PM" term="%2210348461%22">10348461)</searchLink><br />Brain Res. 1996 Oct 7;735(2):317-24. (PMID: <searchLink fieldCode="PM" term="%228911672%22">8911672)</searchLink><br />Ann Neurol. 1995 Dec;38(6):852-61. (PMID: <searchLink fieldCode="PM" term="%228526457%22">8526457)</searchLink><br />Neuroscientist. 2019 Oct;25(5):475-490. (PMID: <searchLink fieldCode="PM" term="%2230678530%22">30678530)</searchLink><br />J Cell Biol. 2005 Dec 19;171(6):1001-12. (PMID: <searchLink fieldCode="PM" term="%2216365166%22">16365166)</searchLink><br />Neuroscientist. 2019 Aug;25(4):359-379. (PMID: <searchLink fieldCode="PM" term="%2230379121%22">30379121)</searchLink><br />Curr Opin Neurobiol. 2004 Dec;14(6):685-92. (PMID: <searchLink fieldCode="PM" term="%2215582369%22">15582369)</searchLink><br />Cureus. 2022 Apr 25;14(4):e24473. (PMID: <searchLink fieldCode="PM" term="%2235651462%22">35651462)</searchLink><br />J Neurosci. 1991 Dec;11(12):3877-87. (PMID: <searchLink fieldCode="PM" term="%221836019%22">1836019)</searchLink><br />Front Synaptic Neurosci. 2019 May 14;11:14. (PMID: <searchLink fieldCode="PM" term="%2231139071%22">31139071)</searchLink><br />Neuroendocrinology. 1996 Feb;63(2):181-7. (PMID: <searchLink fieldCode="PM" term="%229053783%22">9053783)</searchLink><br />J Anat. 2000 May;196 ( Pt 4):527-42. (PMID: <searchLink fieldCode="PM" term="%2210923985%22">10923985)</searchLink><br />Dis Model Mech. 2024 Nov 1;17(11):. (PMID: <searchLink fieldCode="PM" term="%2239526491%22">39526491)</searchLink><br />Neuron. 2016 Jul 20;91(2):260-92. (PMID: <searchLink fieldCode="PM" term="%2227477017%22">27477017)</searchLink> – Name: GrantInfo Label: Grant Information Group: Grant Data: 5R01NS089750 United States NS NINDS NIH HHS; Jarman F. Lowder Endowment; Hereditary Disease Foundation; University of Alabama at Birmingham – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>BACHD; Huntington's disease; Interneurons; Somatostatin; Striatum – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Huntingtin Protein)<br />51110-01-1 (Somatostatin)<br />0 (Mutant Proteins) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260206 <i>Date Completed: </i>20260707 <i>Latest Revision: </i>20260813 – Name: DateUpdate Label: Update Code Group: Date Data: 20260813 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13054931 – Name: DOI Label: DOI Group: ID Data: 10.1242/dmm.052513 – Name: AN Label: PMID Group: ID Data: 41648922 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41648922 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1242/dmm.052513 Languages: – Code: eng Text: English Subjects: – SubjectFull: Anxiety physiopathology Type: general – SubjectFull: Anxiety complications Type: general – SubjectFull: Huntington Disease physiopathology Type: general – SubjectFull: Animals Type: general – SubjectFull: Phenotype Type: general – SubjectFull: Male Type: general – SubjectFull: Motor Activity Type: general – SubjectFull: Mice Type: general – SubjectFull: Interneurons metabolism Type: general – SubjectFull: Huntingtin Protein metabolism Type: general – SubjectFull: Huntingtin Protein genetics Type: general – SubjectFull: Somatostatin metabolism Type: general – SubjectFull: Mutation genetics Type: general – SubjectFull: Mutant Proteins metabolism Type: general – SubjectFull: Behavior, Animal Type: general Titles: – TitleFull: Mutant huntingtin expression in somatostatin-positive interneurons contributes to neurophysiological and behavioral phenotypes in BACHD mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fowler JA – PersonEntity: Name: NameFull: Scarduzio M – PersonEntity: Name: NameFull: Pool C – PersonEntity: Name: NameFull: Mahan CD – PersonEntity: Name: NameFull: Gray M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1754-8411 Numbering: – Type: volume Value: 19 – Type: issue Value: 3 Titles: – TitleFull: Disease models & mechanisms Type: main |
| ResultId | 1 |